AUS
NZ
UK
CA
USA
IND
Health
Intellia Therapeutics (NASDAQ:NTLA) Best Nasdaq Stocks Clinical Innovation
January 15, 2026 12:00 AM PST| By Anmol KhazanchiIntellia Therapeutics (NASDAQ:NTLA) develops CRISPR/Cas9 genome-editing therapies for genetic diseases, positioning the company within biotechnology discussions that include best nasdaq stocks.
Summit Therapeutics (NASDAQ:SMMT) Nasdaq 100 Index Biotech Position
January 15, 2026 12:00 AM PST| By Anmol KhazanchiSummit Therapeutics focuses on developing precision medicines for serious and life-threatening diseases, contributing to biotechnology discussions where the Nasdaq 100 index highlights innovation-driven clinical-stage companies.
Tango Therapeutics (NASDAQ:TNGX) Nasdaq Futures Research-Driven Model
January 15, 2026 12:00 AM PST| By Anmol KhazanchiTango Therapeutics focuses on precision oncology through synthetic lethality research, developing targeted cancer therapies while appearing in broader biotechnology discussions shaped by Nasdaq futures.
Corcept Therapeutics (NASDAQ:CORT) Nasdaq Composite Mechanism Strategy
January 15, 2026 12:00 AM PST| By Anmol KhazanchiCorcept Therapeutics focuses on developing cortisol-modulating therapies for complex metabolic, oncologic, and psychiatric disorders, maintaining visibility in biotechnology discussions associated with the nasdaq composite.
Cardinal Health (NYSE:CAH) S&P 500 ETF Healthcare Infrastructure
January 15, 2026 12:00 AM PST| By Anmol KhazanchiCardinal Health operates as a major healthcare services provider, supporting hospitals and pharmacies worldwide while appearing in broader market conversations that include the s&p 500 etf.
Bioventus Inc (NASDAQ:BVS) Nasdaq 100 Index Clinical Technology Role
January 14, 2026 12:00 AM PST| By Anmol KhazanchiBioventus develops non-surgical orthobiologic therapies for bone healing and musculoskeletal conditions, appearing in broader healthcare discussions where the nasdaq 100 index reflects medical technology participation.
Vir Biotechnology (NASDAQ:VIR) Top 10 Nasdaq Stocks Spotlight on Research
January 14, 2026 12:00 AM PST| By Anmol KhazanchiVir Biotechnology (NASDAQ:VIR) focuses on immunology-driven therapies for infectious diseases, appearing in broader biotech discussions where top 10 nasdaq stocks highlight innovation-led companies.
Azenta Inc (NASDAQ:AZTA) Best Nasdaq Stocks Scalable Research Systems
January 14, 2026 12:00 AM PST| By Anmol KhazanchiAzenta (NASDAQ:AZTA) supports life sciences research through automated sample management, cryogenic storage, and genomic services, maintaining visibility in broader market conversations that include best nasdaq stocks.
UFP Technologies, Inc. (NASDAQ:UFPT) Nasdaq 100 ETF Snapshot
January 13, 2026 12:00 AM PST| By Anmol KhazanchiUFP Technologies (NASDAQ:UFPT) designs custom-engineered plastic and foam components for medical, aerospace, and industrial uses, appearing in broader market conversations that include the nasdaq 100 etf.
Masimo Corporation (NASDAQ:MASI) Nasdaq Composite Signals MedTech Focus
January 12, 2026 12:00 AM PST| By Anmol KhazanchiMasimo (NASDAQ:MASI) strengthens global healthcare through noninvasive monitoring technologies, appearing in broader market discussions where the nasdaq composite highlights medical technology innovators.
ICON plc (NASDAQ:ICLR) Nasdaq Index Healthcare Services Presence
January 12, 2026 12:00 AM PST| By Anmol KhazanchiIcon plc (NASDAQ:ICLR) delivers outsourced clinical research and drug development services worldwide, maintaining visibility in healthcare-focused discussions connected to activity within the nasdaq index.
Scholar Rock (NASDAQ:SRRK) Clinical Biologics In Nasdaq Composite
January 09, 2026 12:00 AM PST| By Anmol KhazanchiScholar Rock focuses on developing protein therapeutics that target growth factor pathways, contributing to biotechnology research narratives often shaped by activity within the nasdaq composite.
Amgen Inc. (NASDAQ:AMGN) aligns with nasdaq composite life sciences
January 09, 2026 12:00 AM PST| By Anmol KhazanchiAmgen (NASDAQ:AMGN) maintains a strong biotechnology presence through global research and biologic development, appearing consistently in broader healthcare discussions connected to the nasdaq composite.
Fortrea, Inc. (NASDAQ:FTRE) Nasdaq Index Fund Integrated Services
January 09, 2026 12:00 AM PST| By Anmol KhazanchiFortrea supports drug development from early research through commercial production, leveraging scientific expertise and manufacturing scale while appearing in broader market discussions linked to the nasdaq index fund.
CG Oncology, Inc. (NASDAQ:CGON) Nasdaq 100 Index Early-Stage Biotech
January 09, 2026 12:00 AM PST| By Anmol KhazanchiCG Oncology (NASDAQ:CGON) develops antibody-based immunotherapies targeting solid tumors, remaining visible in biotechnology discussions shaped by themes associated with the nasdaq 100 index.
Neogen Corporation (NASDAQ:NEOG) Nasdaq 100 ETF Safety Systems
January 09, 2026 12:00 AM PST| By Anmol KhazanchiNeogen Corporation develops diagnostic solutions for food and animal safety, supplying testing systems used worldwide and appearing in broader market discussions that include the nasdaq 100 etf.
NeuroPace (NASDAQ:NPCE) Shapes Precision Neurological Care
January 09, 2026 12:00 AM PST| By Anmol KhazanchiNeuroPace develops closed-loop neuromodulation systems that monitor and respond to brain activity, supporting advanced treatment approaches for neurological disorders through innovative medical device technology.
Tilray Brands (NASDAQ:TLRY) Expands Across Regulated Markets
January 09, 2026 12:00 AM PST| By Anmol KhazanchiTilray Brands develops and distributes cannabis and cannabinoid-based products across medical, recreational, and wellness categories, supported by advanced cultivation, research, and quality control systems.
PTC Therapeutics Inc (NASDAQ:PTCT) Nasdaq Composite Genetic Precision
January 08, 2026 12:00 AM PST| By Anmol KhazanchiPTC Therapeutics focuses on small molecule and biologic therapies for rare genetic disorders, contributing to biotechnology innovation frequently discussed within the nasdaq composite.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Nasdaq Today Specialty Pharma Focus
January 08, 2026 12:00 AM PST| By Anmol KhazanchiANI Pharmaceuticals, Inc, a U.S. specialty pharmaceutical manufacturer offering API development through finished dosage solutions, maintains visibility as nasdaq today tracks activity across healthcare and drug production markets.
